Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/s0090-3019(81)80012-2 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Combination of triple chemotherapy and sequential re-irradiation as salvage for recurrent treatment-refractory hemangiopericytoma of extraspinal dura: a case report.
Front Oncol
November 2024
Division of Abdominal Tumor Multimodality Treatment, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Introduction: Hemangiopericytoma (HPC) in the central nervous system (CNS) is rare. Our report aims to present an HPC case with multiple surgeries at the lumbar spine, and demonstrates an effective treatment as salvage.
Case Report: In this report, we present the case of a young girl with recurrent meningeal invasion of lumbar spinal HPC.
Hemangiopericytoma following allogeneic hematopoietic stem cell transplantation in a patient with primary plasma cell leukemia: the first case report and literature review.
Front Oncol
November 2024
Department of Hematology, The 940th Hospital of Joint Logistics Support Force of Chinese People's Liberation Army, Lanzhou, China.
Background: Hemangiopericytoma (HPC) is a rare secondary tumor after allogeneic hematopoietic stem cell transplantation (allo-HSCT), which has not been reported in the literature. Herein, we reported a case of HPC after allo-HSCT.
Case Description: We reported a case of a middle-aged female patient with primary plasma cell leukemia who presented lumbosacral pain and right lower limb pain and numbness on1684 days post-transplant.
Recurrence of Solitary Fibrous Tumor in the Spinal Cord Following Gross Total and Subtotal Resection: A Case Report of Recurrence 19 Years of Post-total Resection and Systematic Literature Review.
NMC Case Rep J
October 2024
Department of Neurosurgery, University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States.
Spinal cord solitary fibrous tumors (SFTs), previously known as hemangiopericytoma (HPC), represent exceedingly rare neoplasms. Strategies for their management, such as appropriate follow-up duration, remain controversial due to their propensity for recurrence despite extended periods of quiescence. We report a 51-year-old male presenting with new-onset back pain and gait disturbances, who had undergone gross total resection (GTR) of an SFT within the thoracic spinal cord 19 years ago.
View Article and Find Full Text PDFChronic management and recurrent challenges: a case of multifocal spinal hemangiopericytoma over 7 years. Illustrative case.
J Neurosurg Case Lessons
October 2024
Department of Neurosurgery, Academic Hospital of Brandenburg University, Dessau, Germany.
Article Synopsis
- Spinal hemangiopericytoma (sHPC) is a rare tumor that poses significant challenges due to its likelihood of recurrence and spread, making diagnosis and management difficult.
- A 68-year-old female with multifocal sHPC underwent initial spinal surgery followed by years of stability, but later needed further treatments like radiosurgery after new growths were found through MRI.
- The case highlights the need for ongoing monitoring and a collaborative treatment approach, with adaptable strategies to effectively manage the tumor and prioritize patient-centered care.
Spine Stereotactic Radiosurgery Provides Long-Term Local Control and Overall Survival for Benign Intradural Tumors.
Neurosurgery
October 2024
Department of Neurological Surgery, University of Pittsburgh Medical Center, Pittsburgh , Pennsylvania , USA.
Background And Objectives: The role of radiosurgery in the treatment of benign intracranial tumors is well established. However, there are limited long-term follow-up studies on outcomes after stereotactic radiosurgery (SRS) for benign intradural spinal tumors. In this article, we report a large single-institution experience in using SRS to treat patients with benign intradural tumors of the spine.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!